Related Experiment Video
Updated: Jan 15, 2026

In vitro Organoid Culture of Primary Mouse Colon Tumors
Published on: May 17, 2013
PAX9 and Col1A1 may regulate the progression of colon cancer through interactions with the TGF-β1/Smad pathway
Chao Huang1, Bingjun Liang1, Weizeng Shen1
1Department of Traditional Chinese Medicine, Shenzhen Hospital of Guangdong Provincial People's Hospital (The Second Affiliated Hospital of Shenzhen University), Shenzhen 518100, China.
Objective:
Transforming growth factor-β1 (TGF-β1) is widely involved in the progression of advanced cancer through the downstream Smad pathway, but the underlying mechanisms are still not fully understood. This project aimed to explore the relationship between key molecules of the TGF-β1/Smad pathway and the progression of colon cancer, as well as its upstream and downstream regulatory mechanisms.
Methods:
Clinical data and related gene expression data of patients with colon cancer were retrieved from clinical databases and genomic libraries such as TCGA-COAD, GEO, and ENCODE. The expression levels of key molecules of the TGF-β1/Smad pathway (TGF-β1, TGF-β1 receptor, and SMAD2/3/4) in colon cancer/paracancerous tissue samples and their relationships with prognosis were analyzed. R packages and RStudio were used to analyze genes that were differentially expressed between colon cancer and normal tissues and the promoter regions bound by Smad2/3. JASPAR and GO/KEGG enrichment were used to predict upstream transcription factors and downstream regulatory genes of the TGF-β1/Smad pathway.
Results:
A total of 459 patients with colon cancer were included in this study. Different TGF-β1 expression levels significantly affected the overall survival (OS) and disease-free survival (DFS) of patients with colon cancer (P < 0.05). The expression of TGF-β1/Smad pathway molecules was significantly associated with the specific stage of cancer. A total of 954 genes had Smad2/3 binding sites in their promoter regions. The expression of the main transcription factor, paired box 9 (PAX9), that regulates the Smad2/3 pathway was generally higher in colon cancer tissues than in normal tissues. The expression of the transcription factor vitamin D (1,25- dihydroxyvitamin D3) receptor (VDR) was significantly different among different cancer types, especially in colon cancer, where its expression was significantly higher than that in normal tissues. Col1A1 expression was strongly correlated with that of TGF-β1 (R = 0.79, P < 0.001). High expression of COL1A1 tended to reduce overall survival (P = 0.072), and the high-expression group had a 1.6 times lower risk of DFS than the low-expression group did (P < 0.05).
Conclusion:
The TGF-β1/Smad pathway may regulate the progression and prognosis of colon cancer in conjunction with multiple upstream and downstream target genes (including PAX9, VDR, and Col1A1) and is related to cancer stage.
Insights
Transforming growth factor-β1 (TGF-β1) and its Smad pathway significantly impact colon cancer survival and stage. Key molecules like PAX9, VDR, and Col1A1 are implicated in its progression and prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Transforming growth factor-β1 (TGF-β1) signaling via the Smad pathway is crucial in cancer progression.
- The precise mechanisms linking TGF-β1/Smad pathway to colon cancer remain incompletely understood.
Purpose of the Study:
- To investigate the relationship between TGF-β1/Smad pathway molecules and colon cancer progression.
- To explore upstream and downstream regulatory mechanisms of this pathway in colon cancer.
Main Methods:
- Utilized TCGA-COAD, GEO, and ENCODE databases for clinical and gene expression data.
- Analyzed expression levels of TGF-β1, its receptor, and SMAD2/3/4 in colon cancer tissues.
- Employed R packages for differential gene expression analysis and promoter binding site identification.
- Used JASPAR and GO/KEGG for predicting transcription factors and downstream targets.
Main Results:
- TGF-β1 expression levels significantly correlated with overall survival (OS) and disease-free survival (DFS) in 459 colon cancer patients.
- Pathway molecule expression varied with cancer stage.
- Identified 954 genes with Smad2/3 binding sites; PAX9 and VDR showed altered expression in colon cancer.
- Col1A1 expression strongly correlated with TGF-β1 and was associated with survival outcomes.
Conclusions:
- The TGF-β1/Smad pathway, along with target genes PAX9, VDR, and Col1A1, plays a role in colon cancer progression and prognosis.
- Pathway activity is linked to cancer stage and survival, suggesting therapeutic potential.
Related Concept Videos
TGF - β Signaling Pathway
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Pleiotropy

